- Home
- GSHD vs APLS Comparison
GSHD vs APLS Comparison
Compare GSHD & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSHD
- APLS
- Stock Information
- Founded
- GSHD 2003
- APLS 2009
- Country
- GSHD United States
- APLS United States
- Employees
- GSHD N/A
- APLS N/A
- Industry
- GSHD Specialty Insurers
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- GSHD Finance
- APLS Health Care
- Exchange
- GSHD Nasdaq
- APLS Nasdaq
- Market Cap
- GSHD 2.7B
- APLS 2.3B
- IPO Year
- GSHD 2018
- APLS 2017
- Fundamental
- Price
- GSHD $108.37
- APLS $17.44
- Analyst Decision
- GSHD Buy
- APLS Buy
- Analyst Count
- GSHD 10
- APLS 19
- Target Price
- GSHD $115.40
- APLS $37.50
- AVG Volume (30 Days)
- GSHD 296.7K
- APLS 3.0M
- Earning Date
- GSHD 04-23-2025
- APLS 05-07-2025
- Dividend Yield
- GSHD 5.45%
- APLS N/A
- EPS Growth
- GSHD 129.07
- APLS N/A
- EPS
- GSHD 1.26
- APLS N/A
- Revenue
- GSHD $324,757,000.00
- APLS $775,839,000.00
- Revenue This Year
- GSHD $18.40
- APLS $1.54
- Revenue Next Year
- GSHD $24.82
- APLS $22.80
- P/E Ratio
- GSHD $86.19
- APLS N/A
- Revenue Growth
- GSHD 21.87
- APLS 48.04
- 52 Week Low
- GSHD $54.80
- APLS $16.10
- 52 Week High
- GSHD $130.39
- APLS $43.76
- Technical
- Relative Strength Index (RSI)
- GSHD 51.48
- APLS 42.89
- Support Level
- GSHD $104.53
- APLS $17.07
- Resistance Level
- GSHD $114.76
- APLS $19.02
- Average True Range (ATR)
- GSHD 3.56
- APLS 1.05
- MACD
- GSHD 0.76
- APLS 0.15
- Stochastic Oscillator
- GSHD 54.98
- APLS 32.84
About GSHD Goosehead Insurance Inc.
Goosehead Insurance Inc operates as an insurance agency. Its insurance products consist of homeowner's insurance; auto insurance; other personal lines products including flood, wind and earthquake insurance; excess liability or umbrella insurance; specialty lines insurance (motorcycle, recreational vehicle and other insurance); commercial lines insurance (general liability, property, and auto insurance for small businesses); and life insurance. Geographically, it operates in Texas, California, Illinois, Florida, and other regions.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.